This prospective study examines a population based cohort of 115 Coloradans identified as having an acute traumatic spinal cord injury by the Spinal Cord Injury Early Notification System in 1989. Comprehensive medical cost and complication data were collected for the first 2 years of survival. Unlike previous cost studies, this group represents the broad spectrum of spinal cord injured persons, reflected in a truly population based sample. Nearly 22 million dollars were spent during the first 2 years post injury on behalf of these Coloradans. Care provided to the 27 persons with Frankel A, B or C tetraplegia accounted for $10.9 million (50%); $7.6 million (35%) was spent providing care for the 36 people with Frankel A, B or C paraplegia; and the remaining $3.3 million (15%) was required for services provided to the 52 persons who had resolved to either Frankel D or E at acute care discharge. Of the $6.3 million that was spent post hospital discharge, $2.5 million (39%) is directly attributable to in-home care, and another $2.0 million (32%) is directly attributable to secondary medical complications. The most expensive complications occurred in the neurological, skin, respiratory and orthopedic body systems.
Introduction
Injuries of all etiologies and severity are an important contributor to the health care burden of Americans. Rice and MacKenzie report that the total lifetime cost for the 57 million persons who sustained injuries in the United States during 1985 will impose a $158 billion burden on the national economy.
' Although spinal cord injury (SCI) is proportionately rare as compared to other injuries (according to Rice and MacKenzie, those who survived traumatic SCI accounted for only 0.6% of persons hospitalized for an injury in 1985 1 ) its results are frequently life changing and demand a high volume of medical services over the lifetime of the survivor. Li�etime co � t ' proj � c�ions for an individual survivin} a splllal cord lllJury IS III excess of one mtlhon dollars. · 4 Early work in the area of describing the cost of spinal cord injuries can be divided into two categorical groups. First, there is the work that focused on a particular etiology of injury, S -8 including motor vehicle crashes and occupational incidents. Since the spectrum of SCI severity differs with causes of SCI, these studies are not generalizable to the whole population of spinal cord injured persons.
Second, a number of studies focus on data from a specific hospital or hospital system that specialize in the treatment of persons with SCI. 9 -1 S The numerous studies presented by the Model Regional SC I Centers make up the bulk of these facility-specific studies.
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Contributions from the Model Systems include works that are focused at only one facilitl· 15 and those that were an aggregate of more than one Model System Hospital's data. IO -14 Other facility-specific studies include a pair of studies from Independent Living Centers in Boston and Worcester, MA 17.I S and a contribution from Toronto Canada. 16 Again, these works focus on describing the experiences of specialized SCI treatment centers. Each of the preceding studies has made important contributions to the understanding of the costs associated with spinal cord injury. However, both individually and corporately, they fail to describe the breadth of cost that is experienced by persons of all etiologies of SCI or by persons seen at all types of medical facilities. Most importantly, these previous studies do not give adequate consideration to persons who sustain a SCI and have significant enough recovery so as to be discharged directly home from the acute care hospital. They have, indeed laid the foundation for a new spectrum of SCI cost investigations that are more representative of all SCI survivors regardless of their treatment facility or etiology of injury.
This new category of work has not only moved toward including a more complete spectrum of persons with SCI, but it has been more extensive in its approach to obtaining accurate measures of costs. DeVivo and colleagues conducted a prospective one year cost study which occurred during 1989 and 1990 . A random sample of 508 previous participants in the Model System National SCI Data base and 227 newly injured participants in the National SCI Database were selected. One year of total SCI related medical charge data were collected through the use of periodic telephone interviews and National SCI Database abstraction. Charges were verified by either the provider or the third party payor. DeVivo reports a first year mean cost (1992 dollars) of $198,335 and mean annual follow-up year charges of $24,154 per spinal cord injured person. The most severely injured group of patients had mean first year charges of $417,067 while the least severely injured group's mean first year charges were $122,914. Similarly, the most severely injured group's mean annual follow-up charges were higher at $74,707 while the least severely injured group's mean charges were considerably lower at $8614. 4 The strength of the DeVivo work is clearly in the methodological design of cost ascertainment. The approach is thorough and comprehensive and is based on actual documented charges. The weakness of this study is in the lack of representativeness of the sample of spinal cord injured individuals. Participants who experience SCI resulting in paralysis severe enough to be seen at specialty Model Systems Centers are not necessarily representative of all persons with SC I.
Berkowitz et al report an annual national expendi ture of $3.4 billion for the care of persons with traumatic spinal cord injuries (1988 dollars). They estimate an additional $2.2 billion is accrued annually in indirect costs. This team investigated the costs accrued by a probability sample of 758 SCI persons living in both the community and institutional settings. This sample was drawn using a community sampling scheme, an institutional sampling scheme, and the Paralyzed Veterans of America's membership list. The participants responded to a detailed questionnaire. The services and medical items used by these persons were then given an estimated value based largely on average prices for hospitalization, practitioner visits, etc., calculated over the general US population. The 1988 pricing of medical goods and services was derived from a variety of secondary data sources, including government, industry and trade association publica tions. This study reports a mean first hospitalization and medical expense cost of over $95,000, an average annual cost of over $14,000. This study does not take into consideration any persons who did not survive their initial trauma or acute care phase of treatment. 2 , 3
The Economic Consequences approach is superior for its case sampling design (it attempts to get a representative sample of all levels and functioning after spinal cord injury), however its weak link is in 19 While limited to only a portion of initial expenses, this work emphasizes the importance of cost studies addressing more represen tative samples.
The study presented here is the logical next step to these works. The population based registry group insures that the mixture of levels and severity of injuries that are included are really those that occur across a population. And, the thorough follow-up cost ascertainment strategies with collection of service provider names from medical record reviews and telephone interviews with participants, followed by collection of billing information directly from the providers, insures the accuracy of the cost data.
Two main study questions are addressed. What are the first two years of charges related to medical services for a population-based registry group of persons with SCI? What are the charges for follow up complications among this population?
Methodology

Study population and classification
The study population includes all 115 cases of traumatic spinal cord injury, who survived to hospital admission, among Colorado residents, during 1989. This includes all cases identified by the Colorado Spinal Cord Injury Early Notification System (EN S), a statewide spinal cord injury surveillance effort, during the 1989 surveillance cycle. *Completeness of statewide surveillance is assured by a multi-pronged method of case identification including both clinical liaisons phoning in new injuries and retrospective medical records surveillance using ICD-9 codes. Accuracy of the SCI diagnosis is assured by careful medical record review for spinal cord related neurological deficits prior to inclusion of cases into the data set. The recorded incidence of SCI during 1989 in Colorado was 36.5 cases per million who presented alive at the hospital emergency room. 2l This rate is slightly higher than the often quoted incidence of 32.2 cases per million, reported by Kraus and colleagues, 22 serving as additional evidence of the completeness of this popUlation based group.
The severity of each participant's injury was classified by both the vertebral level of injury and by the Frankel Classification 20 (rating of motor and sensory function below the level of injury) at the *Five addtional cases, which occured during 1989, were identified during subsequent surveillance cycles and are not included in this report. All of these late identified cases had functional movement below their level of injury upon acute hospital discharge time of discharge from the acute care hospital. These two classifications were used to separate the partici pants into four groups based on the overall severity of their SCI. These groups are as follows: t Group 1: Injury level cervical 1-4 with Frankel Grade A, B or C (high tetraplegia). Group 2: Injury level cervical 5 -8 with Frankel Grade A, B or C (low tetraplegia). Group 3: Thoracic, lumbar and sacral injury level with
Frankel Grade of A, B, or C (paraplegia). Group 4: All Frankel Grade D and E regardless of injury level (incomplete paralysis, typically allowing ambulation). This classification scheme was chosen because of the functional similarity found within the groups. Under this scheme the potential for misclassification of cases is minimized. Since SCI survivors in each of the Frankel A, B and C categories function similarly, it is possible to achieve valid classification even in the absence of specific motor and sensory testing.t Injuries that occurred to other body systems at the same time as the SCI was sustained have not been considered as a part of this study.
Cost ascertainment
Initials ENS case records and identification informa tion were used to contact the 115 persons who were reported to the ENS during 1989 and solicit their participation in this study. Extensive interviews were conducted asking participants about their use of medical services, their procurement of medical supplies and durable medical equipment, their use of assistance in the home, and the names of all providers. Additionally, medical records of all hospital admis sions were reviewed to identify additional providers. Billing information was obtained directly from providers.
The costs incurred during the first year are divided into specific service utilization categories. Additionally, data concerning volume of utilization have also been encoded for this study.
Data for each of the utilization categories have been classified for level of accuracy according to a three tiered scheme. (1) Actual documented costs for which a bill was obtained, (2) estimated costs based on identical services, and in rare instances, (3) estimated costs based on similar services.
The follow-up cost data were paired with a specific body system or nature of admission wherever possible. These body system classifications include: respiratory; urological/bladder/renal; skin; gastro-intestinal; neurotWhile 14 participants experienced enough recovery after acute care discharge to switch groups at some point during the 2 year study, all participants were retained in their original groupings for analysis. tMisclassification, should it have occurred at the time of original coding of the ENS records would have been more likely to have taken place within the Frankel Classifications of A, B and C, or within the Frankel Classifications of D and E rather than across these two major groups. Combining Frankel Classifications in this way minimizes the effects of initial errors in coding. The use of this scheme is also supported by DeVivo et al. 4 logical; orthopedic; injury; pain; gynecological; psy chological; circulatory; concomitant injury; endocrine; fatigue; general follow-up.
All costs for the 2-year period have been adjusted to the 1992 dollar value, using the Medical Care Component of the Consumer Price Index. Statistical comparisons between the four injury groups were made using the Kruskal-Wallis non-parametric meth od for analysis of variance.
Results
Of the 115 participants of this study 11 were categorized as Group 1 (high tetraplegia), 16 as Group 2 (low tetraplegia), 36 as Group 3 (para plegia)and 52 as Group 4 (incomplete paralysis). One hundred and six of the participants survived into their second year post injury. ** For those who died, cost data have been included for the period between injury and death and then the participant was excluded from subsequent analysis periods. Among the 115, 82 (71 %) agreed to provide the requested interview. For the remaining 29%, medical record reviews served as the source of providers and follow-up care. This informa tion source was available on all the cases, regardless of their participation with the interview, since SCI is a reportable condition in Colorado.
A total of 8864 hospital days were used by the study participants. Additionally, 1178 extended care facility days were used. Of the hospitalization days, 2695 were spent in initial acute care, 5564 were spent in initial rehabilitation and 605 were readmission days. Figure 1 shows the mean, median, interquartile range, and maximum and minimum length of hospitalization stays for the 106 persons who survived into their second year post injury, by injury severity group. Length of initial hospitalization (including both acute care and rehabilitation hospitalization) is significantly associated with injury severity (/3=53.75, P<O.OOI), however, length of readmission was not (/3 = 8.84, P = 0.051). It should be noted that the median number of readmission days for the low tetraplegia, the paraplegia, and the incomplete paralysis groups were all zero days.
A total of $21,727,290, in 1992 dollars, has been documented as the first 2-year charges incurred by this population of 115 SCI survivors. Of this, $17,624,900 (81.1 %) are documented by the collection of actual **Five participants with high tetraplegia died, one during acute care, two during rehabilitation and two during the second year post injury. Three participants with low tetraplegia died, one during acute care and two during the first year post injury. One participant with paraplegia died during the first year post injury. Two participants with incomplete paralysis died during the first year post injury.
Additionally, at the time of discharge from rehabilitation one of the Group I and one of the Group 2 participants remained ventilator dependent. The Group I participant who remained ventilator dependent at discharge from rehabilitation survived into their second year post injury, while the Group 2 participant was discharged after 180 days of rehabilitation to an acute care facility where they expired. 
The initial hospitalization phase, including both acute care and rehabilitation accounted for $15,454,013 (71.1 %) of the total dollars spent. Mean and median charges for hospitalization and physician care during the initial acute care and rehabilitation hospitalization periods are displayed, by injury group, in Table 2 . Significant differences between injury groups (X23 = 52.2, P < 0.00 1), are seen during the initial hospitalization phase of care for hospitalization and physician charges during both the acute care and rehabilitation phases. Both of the tetraplegia groups had charges which were much greater than the charges for either the paraplegic or the incomplete paralysis groups.
The $6,273,277 not spent on initial hospitalization and reha bilitation was spent on all categories of follow-up costs. During the period from initial discharge to the first year anniversary of injury a total of $3,258,140 dollars was expended while $3,015,137 dollars was spent in the second year after injury. Table 3 presents the mean and median follow-up care dollar amounts, by injury group, for each of these categories of service during both the first year and the second year following injury. While the total costs for these years of follow-up differed by severity of injury (n= 106, /3=60.0, P<O.OOI), it should be noted that during year one, readmission charges, physician charges and miscellaneous expenses did not differ significantly among the four severity groups. Similarly, the year two readmission charges and miscellaneous expenses did not differ significantly.
Within each of the four phases of care, acute care, rehabilitation, year one follow-up, and year two follow-up, the total charges generated during that phase were significantly associated with the severity of To address the second major question of this study injury group. Figure 2 displays the mean, median, regarding the cost of secondary complications, the interquartile ranges and range for both the initial follow-up costs were analyzed in greater detail. Table  inpatient and the follow-up periods of care.
4 divides the total 2 year follow-up costs into two During the follow-up periods, 91 of the participants had documented one or more occurrence of receiving medical care for either general SCI follow-up or for a secondary complication. A total of 457 occurrences of either general follow-up or a secondary complication were identified by ICD-9 codes that had been coded in Table 5 Charges associated with general follow-up evaluation and specific body system complications (1992 Dollars, n = Ill) conjunction with services provided to these 91 partICIpants. Of these 457 occurrences, 83 were for general follow-up and 374 were for secondary complications. This is less than one general follow-up occurrence per person during the 2 years and is more than three medical occurrences per person for complications during that same 2-year period. In 133 of the 374 instances of treatment for secondary complications, only one complication presented and the charges could be attributed directly to that complication. The remaining 241 complications presented in multiple occurrences where more than one complication was treated simultaneously and costs could not be split among the complications. Costs were approximately equally divided among these categories -$959,148 for individual complications and $1,034,860 for multiple complications.
A complete breakdown of both the frequency and expense associated with each complication of a body system is presented in complications were the most frequently identified complications. It was skin, neurologic and orthopedic complications that had the most total costs directly attributable to a specific body system. On the other end of the spectrum gynecological, endocrine and fatigue-related complications were identified, but in no case could specific dollars be attributed to them. The secondary conditions and complications were represented in varying proportions among the four injury severity groups. The participants with high tetraplegia experienced respiratory and neurological complications as the highest expense categories. The eight participants with high tetraplegia who survived into the follow-up period reported a total of 60 complications or 7.5 complications per person. Fifteen of the participants with low tetraplegia, survived into the follow-up period. These partici pants had their highest charges associated with skin and neurological complications. This group reported a total of 81 complications or 5.4 complications per person. For the participants with paraplegia, the largest expenses were seen in the categories of neurological, skin and orthopedic complications. All 36 of these participants survived into the follow-up period and they reported a total of 187 complications or 5.2 complications per person. Similarly, the participants with incomplete paralysis experienced their highest charges in the areas of orthopedic, skin and neurological complications. Again, all 52 of these participants survived into the follow-up period and they reported a total of 46 complications or 0.9 complications per person.
Discussion
These data present for the first time a cost picture of spinal cord injury as it occurs in a population. The volume of costs that are presented here are supportive of previous SCI cost-related work in that they are consistent with the finding that cost of injury is highly correlated with severity of injury. This correlation is now documented not only among survivors treated at a SCI Model Systems of Care, but also among the population of all SCI survivors. Of the 115 persons, in this study, 30% used no inpatient rehabilitation services, 40% of them received rehabilitation at the Regional Spinal Cord Injury Model System and 30% received rehabilitation at other area rehabilitation units. At the same time these data substantially add to the accuracy of our knowledge, as it relates to persons with spinal cord injuries who experience enough recovery during the acute phase that they do not require inpatient rehabilitation. In applying these data to large groups of SC I survivors it is important to keep in mind the effect of case mix on total overall costs. It is possible that the case mix of this study examining I year of SCI survivors in Colorado is not representative of the case mix of all injuries occurring nationally. However, the mix of patients represented here is indeed representa tive of the case mix of cases in Colorado from 1990 to 1993 ·tt As the data presented here are applied to individual cases for cost projection purposes a few limitations must be considered. First, although the size of the entire population is fairly large, 115 persons, when divided into the four groups, based on injury level and severity, the number of persons in the two most severe categories is quite small. Additionally, the cost is quite variable and skewed as can be seen in Figure 2 . Both of these together lead to a decreased confidence in the precision of the mean as it applies to any specific individual. Further research with larger samples of severe injury survivors will be valuable.
Another consideration, in applying these data to the individual case, is that these costs represent the services that have been rendered, not the services that were optimal for care. In fact many services could have been needed and not rendered. And finally, in regards to applying cost data to the individual case for cost projection purposes, experienced clinical judge-ment concerning the medical course of a specific individual with an extremely complicated course must be considered.
Comparisons between this study and the two most recent comprehensive SCI cost publications are displayed in Table 6 . In comparing this study with DeVivo et at differences between the two studies in the first year total mean cost were significant for the participants with incomplete paralysis ($122,914 in DeVivo et at vs $60,267 in the current study, t 12 8 = 5.79, P<O.OOl). Differences in cost were not significant for either the high tetraplegia group, the low tetraplegia group or the paraplegic group. Similarly, when adjusted for severity of case mix, the overall first year means are not significantly different. The significant difference among the incomplete paralysis group is a direct reflection of the 30 Frankel D or E participants, in the current study, who did not go to inpatient rehabilitation.
An additional difference between the DeVivo et at sample and the one used here is the time frame in which the measures of injury classification were determined. Injury group classification was deter mined at the time of acute care discharge for this study and at either the time of rehabilitation discharge or reevaluation in the DeVivo et at study. It is possible that some of the Group 1, 2 and 3 participants had experienced recovery and changed groupings during the course of the study. If patients changed groups in this direction the mean charges of all groups would be increased. This, however, would not effect the total mean charges experienced by the entire group.
Despite the differences between the participant classification methodology used by Berkowitz et at and that used here and by DeVivo et at a couple of trends can still be observed (but not tested for significance) after the dollars presented are adjusted to 1992. First, for participants with functionally complete injuries, the Berkowitz study consistently estimated costs much lower than the actual documen ted costs found by both DeVivo et at and this study. This difference is not adequately explained by the classification scheme, since the scheme utilized by Berkowitz et at would have suggested higher rather than lower costs. Given the greater accuracy of cost ascertainment by DeVivo et at and this study, it would appear that their higher cost data are more valid.
While for complete injuries Berkowitz consistently estimated lower cost, for incomplete injuries Berkowitz et al estimated higher first year costs for incomplete paralysis participants. This again demonstrated the impact of a population-based sample of Frankel D and E injuries, which consistently lowers the cost experience of this group.
The Price, et al classification scheme, like the Berkowitz scheme, is not directly comparable to that presented in this study. However, among the acute care and rehabilitation costs presented, it is observed that the total median cost ($53,410, 1989 dollars) for all patients receiving acute care and rehabilitation when inflated to the 1992 dollar level ($65,630) is considerably less than the total median ($104,355) initial hospitalization charges presented here. An important and costly difference is that the current study includes physician charges during this hospita lization period, where as Price et al does not.
These population-based data allow more accurate planning of the resources needed in providing medical services to persons who have sustained a traumatic spinal cord injury within a population as a whole. Persons sustaining tetraplegia account for 23% of the persons injured annually, and they utilized 46% of the initial hospitalization dollars spent and 61 % of the follow-up dollars. Persons who sustained para plegia account for 31 % of the persons injured annually, and they utilize 37% of the initial hospitalization dollars and 29% of the follow-up dollars. Finally, the persons who sustained function ally incomplete paralysis who comprise 45% of the annual injuries, consumed 17% of the initial inpatient charges and 10% of the follow-up charges. The large amount of follow-up dollars consumed by persons with tetraplegia are in large part due to the cost of in-home care. Thirty-nine percent ($2.5 million) of the follow-up dollars were spent on in-home care. Of these in-home care expenditures, 90% went for services provided to persons with tetraplegia, 7% to persons with paraplegia, 3% to persons with incomplete paralysis. Additionally, persons with both high and low tetraplegia had higher rates of complications than did persons with either paraplegia or incomplete paralysis.
These data also allow more accurate planning of the resources needed in both planning for and providing intervention of complications secondary to SCI. As one considers the impact of this secondary complica tions data for the purpose of prevention, two approaches could be taken. First, one could target the most frequently reported body systems in which complications occur. Using this approach the targeted body systems would be urological, skin, pain and gastro-intestinal related, which account for 48% of the complications. A second approach is to target the most expensive complications. This would direct interventions at the neurological, skin, respiratory and orthopedic complications. These four categories of follow-up costs account for 57% of the follow-up dollars that were identified as attributable to a specific body system.
In evaluating secondary complications we were not able to separate the charges for complications that occurred simultaneously. While this has the potential of either over or under estimating the cost of specific complications, it should be noted that the average cost of unattributable complications was less than the average cost of complications where costs could be attributed.
In preventing secondary complications, closer routine follow-up may be warranted. The present study demonstrated that the dollars spent on treating secondary complications was over six times greater than the dollars spent on routine medical evaluations. On the other hand, many of the participants in this study reported complications in the high cost categories before they became high cost. This indicates that complications can potentially be identified when they are in less severe and less costly stages and interventions implemented.
